A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback